Literature DB >> 26192220

Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis.

Mauro Bernardi1, Richard Moreau2, Paolo Angeli3, Bernd Schnabl4, Vicente Arroyo5.   

Abstract

The peripheral arterial vasodilation hypothesis has been most influential in the field of cirrhosis and its complications. It has given rise to hundreds of pathophysiological studies in experimental and human cirrhosis and is the theoretical basis of life-saving treatments. It is undisputed that splanchnic arterial vasodilation contributes to portal hypertension and is the basis for manifestations such as ascites and hepatorenal syndrome, but the body of research generated by the hypothesis has revealed gaps in the original pathophysiological interpretation of these complications. The expansion of our knowledge on the mechanisms regulating vascular tone, inflammation and the host-microbiota interaction require a broader approach to advanced cirrhosis encompassing the whole spectrum of its manifestations. Indeed, multiorgan dysfunction and failure likely result from a complex interplay where the systemic spread of bacterial products represents the primary event. The consequent activation of the host innate immune response triggers endothelial molecular mechanisms responsible for arterial vasodilation, and also jeopardizes organ integrity with a storm of pro-inflammatory cytokines and reactive oxygen and nitrogen species. Thus, the picture of advanced cirrhosis could be seen as the result of an inflammatory syndrome in contradiction with a simple hemodynamic disturbance.
Copyright © 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ascites; Bacterial translocation; Cardiovascular dysfunction; Cirrhosis; Peripheral arterial vasodilation hypothesis; Pro-inflammatory cytokines; Renal dysfunction; Systemic inflammation

Mesh:

Substances:

Year:  2015        PMID: 26192220     DOI: 10.1016/j.jhep.2015.07.004

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  121 in total

Review 1.  Bacterial Infection in Patients with Cirrhosis: Don't Get Bugged to Death.

Authors:  Mary D Cannon; Paul Martin; Andres F Carrion
Journal:  Dig Dis Sci       Date:  2020-01       Impact factor: 3.199

2.  Is small intestinal bacterial overgrowth a cause of hyperdynamic circulation in cirrhosis?

Authors:  Roman Maslennikov; Chavdar Pavlov; Vladimir Ivashkin
Journal:  Turk J Gastroenterol       Date:  2019-11       Impact factor: 1.852

3.  [Red blood cell distribution width is a independent prognostic indicator for mortality in patients with HBV related acute-on-chronic liver failure].

Authors:  Jiao Qin; Li Qiang; Wen Chen; Gang Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-11-30

4.  AISF-SIMTI position paper on the appropriate use of albumin in patients with liver cirrhosis: a 2020 update.

Authors:  Paolo Caraceni; Paolo Angeli; Daniele Prati; Mauro Bernardi; Pierluigi Berti; Francesco Bennardello; Francesco Fiorin; Pierluigi Piccoli
Journal:  Blood Transfus       Date:  2020-12-18       Impact factor: 3.443

Review 5.  New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.

Authors:  Gennaro D'Amico; Alberto Morabito; Mario D'Amico; Linda Pasta; Giuseppe Malizia; Paola Rebora; Maria Grazia Valsecchi
Journal:  Hepatol Int       Date:  2017-07-05       Impact factor: 6.047

6.  Microalbuminuria, systemic inflammation, and multiorgan dysfunction in decompensated cirrhosis: evidence for a nonfunctional mechanism of hepatorenal syndrome.

Authors:  Vicente Arroyo
Journal:  Hepatol Int       Date:  2017-01-25       Impact factor: 6.047

Review 7.  Liver - guardian, modifier and target of sepsis.

Authors:  Pavel Strnad; Frank Tacke; Alexander Koch; Christian Trautwein
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 46.802

Review 8.  Acute-on-chronic liver failure in liver transplant candidates with non-alcoholic steatohepatitis.

Authors:  Iliana Doycheva; Paul J Thuluvath
Journal:  Transl Gastroenterol Hepatol       Date:  2020-07-05

Review 9.  Kidney-liver pathophysiological crosstalk: its characteristics and importance.

Authors:  Olivia Capalbo; Sofía Giuliani; Alberta Ferrero-Fernández; Paola Casciato; Carlos G Musso
Journal:  Int Urol Nephrol       Date:  2019-09-23       Impact factor: 2.370

10.  Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis.

Authors:  Roman Maslennikov; Chavdar Pavlov; Vladimir Ivashkin
Journal:  Hepatol Int       Date:  2018-10-04       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.